AzTrials
AzTrials

Anorexia NervosaCAPANOXNCT02995226

Abnormal Regulation, Estimation and Cognitive Impacts of Physical Efforts as an Endophenotype of Anorexia Nervosa

A study testing Clinical and biological examination, Saliva (or blood) test Glycemia, thermal test, cognitive and bike tests, questionnaires and Clinical examination, Glycemia, saliva (or blood) test, thermal test, cognitive and bike tests, questionnaires in people with Anorexia Nervosa, run by Centre Hospitalier St Anne at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to check if patients, but also relatives (as they share familial and genetic risk factors), are having more difficulties in regulating a spontaneous, pleasant physical effort (doing "too much") compared to healthy controls, and if physical efforts are participating to core symptoms of… Read more about this study

Who is it for?
Ages 18 to 50 years, women onlyHealthy volunteers can take part
Conditions the study is for
Anorexia Nervosa
What is being tested?
Clinical and biological examination, Saliva (or blood) test Glycemia, thermal test, cognitive and bike tests, questionnaires and Clinical examination, Glycemia, saliva (or blood) test, thermal test, cognitive and bike tests, questionnaires
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
1 siteFrance
Study dates
27 Feb 2017to Sep 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients :
  • Woman
  • 18 - 50 years
  • eating disorders (with or without bulimia) according to the EDI-2 (Eating Disorder Inventory) and the MINI (Mini International Neuropsychiatric Interview)
  • BMI (Body Mass index) between 14 and 17,5
  • first degree relative without ED (eating disorders)
Show all 17Show fewer
  • First degree relatives :
  • Woman
  • 18 - 50 years
  • Mother or sister of patient with eating disorders
  • BMI (Body Mass index) upper to 17,5
  • Healthy of all ED (eating disorders)
  • Controls :
  • Woman
  • 18 - 50 years
  • BMI > 17,5
  • Without ED (eating disorders)

Who cannot join

  • All groups :
  • Contraindication in the practice of an intensive sport
  • Cardiovascular Family history with risk of cardiovascular unwanted events
  • Cardiovascular, surgical personal Histories, ostéoarticulaires or musculo-tendinous against indicating to the practice of a sport
  • Intercurrents psychiatric pathologies (humor or psychotics disorders, chronic or acute)
  • Related and controls :
  • Diagnosis of ED (eating disorders) in the EDI-2 and in the MINI

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Centre Hospitalier Sainte Anne

    Paris, 75014

    Philip GORWOOD, MD., PhD, 0033 1 45 65 86 39, p.gorwood@ch-sainte-anne.fr

    Sylvie DOROCANT, 0033 1 45 65 77 28, s.dorocant@ch-sainte-anne.fr

    Recruiting

Other trials in France

About this study

Official title: Analysis of the Capacity to Regulate Physical Efforts and to Estimate Its Intensity as an Endophenotype of Anorexia Nervosa, Because of a Specific Impact of the Physical Effort at the Emotional, Cognitive, Pain, Genetic and Biological Level

The purpose of this study is to check if patients, but also relatives (as they share familial and genetic risk factors), are having more difficulties in regulating a spontaneous, pleasant physical effort (doing "too much") compared to healthy controls, and if physical efforts are participating to core symptoms of anorexia nervosa, such as more appetite (instead of less), less pain, more abnormal body image, and less cognitive flexibility.

Such a result could help to further understand the role of difficulties with physical exercise as part of the phenotype of anorexia nervosa.

Read the detailed description

This is a three steps protocol. First, patients (with anorexia nervosa), controls (with no eating disorder) and first degree relatives (with no eating disorder) will be tested for emotional accuracy (seing faces on a screen with different core emotions), pain threshold (how long they can support a cold probe), body size (how they see themselves), appetite and cognitive flexibility (a test where the capacity to change rules during a game is done easily or not).

Then all subjects will do a standardized physical exercise which represents an effort with the equivalent level of energy for each participants as being chosen according to each level of competency (assessed through the "maximal aerobic power").

The third step consists in the repetition of (nearly) initial tests.

Being tested
Clinical and biological examination, Saliva (or blood) test Glycemia, thermal test, cognitive and bike tests, questionnaires, Clinical examination, Glycemia, saliva (or blood) test, thermal test, cognitive and bike tests, questionnaires
Medical subject headings
Anorexia Nervosa

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Clinical and biological examination, Saliva (or blood) test Glycemia, thermal test, cognitive and bike tests, questionnairesOther

    Clinical and biological examination, Saliva (or blood) test, glycemia, thermal test, cognitive and bike tests, questionnaires

  • Clinical examination, Glycemia, saliva (or blood) test, thermal test, cognitive and bike tests, questionnairesOther

    Clinical examination, Glycemia, saliva (or blood) test, thermal test, cognitive and bike tests, questionnaires

Study groups in NCT02995226
Study groupRoleWhat they receive
Anorexia nervosaOtherPatients with DSM-5 criteria of "anorexia nervosa"
Receives: Other: Clinical and biological examination, Saliva (or blood) test Glycemia, thermal test, cognitive and bike tests, questionnaires
First degree relativesOtherFirst degree relatives (of patients suffering from anorexia nervosa) with no eating disorder
Receives: Other: Clinical examination, Glycemia, saliva (or blood) test, thermal test, cognitive and bike tests, questionnaires
Controls (with no eating disorder)OtherOther
Receives: Other: Clinical examination, Glycemia, saliva (or blood) test, thermal test, cognitive and bike tests, questionnaires

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Physical power

    Comparison inter and intra individual of the subjective and objective power to the subjects during a typical physical bike test.

    Measured: Day 0

Secondary outcomes (8)
  1. Pain threshold

    This threshold is based on the minimum temperature that the patient is able to suppor (the probe is placed on the skin of the forarm, and the temperature reduces its temperature every 10 seconds), knowing that the machine is not getting to temperatures that can be damageable.

    Comparison before and after bike test

    Measured: Day 0

  2. Wellbeing self-questionnaire

    Comparison before and after bike test

    Measured: Day 0

  3. Hunger Visual analogical scale

    Comparison before and after bike test

    Measured: Day 0

  4. PANAS score (self-questionnaire)

    Emotions. Comparison before and after bike test

    Measured: Day 0

  5. Hunger Visual analogical scale

    Apetite. Comparison before and after bike test

    Measured: Day 0

  6. Performance on the Briton cognitive test (number of errors)

    Mental flexibility. Comparison before and after bike test

    Measured: Day 0

  7. Performance on cognitive tests (speed, number of errors), before versus after the exercise, in the three groups.

    Tests. Performance on cognitive tests (speed, number of errors), before versus after the exercise, in the three groups.

    Measured: Day 0

  8. Genetical analysis

    10 candidate genes will be analyzed (following the collection of blood or saliva) assessing the frequency of their main alleles (variants), looking for a significant difference of allele frequency between the 3 groups.

    Measured: Day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Dec 2016 (estimated)
  2. Study start27 Feb 2017
  3. Primary completionApr 2020 (estimated)
  4. Study completionSep 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02995226
Sponsor's protocol ID
D15-P018
Acronym
CAPANOX
Status last verified
Jan 2018
First submitted
5 Dec 2016
Last updated
25 Jan 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Clinical and biological examination, Saliva (or blood) test Glycemia, thermal test, cognitive and bike tests, questionnaires and Clinical examination, Glycemia, saliva (or blood) test, thermal test, cognitive and bike tests, questionnaires in people with Anorexia Nervosa, run by Centre Hospitalier St Anne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 17 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Philip GORWOOD, MD, PhD (00 33 45 65 86 39, p.gorwood@ch-sainte-anne.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Physical power (time frame: Day 0). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jan 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in